xcellbio

Xcell Biosciences (xcellbio) is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcells mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through...

Primary cell culture,cancer,stem cell,immunotherapy,immunooncology,cell therapy,immune cells,and car-t

Xcellbio operates in the Biotechnology research industry.

Xcellbio's revenue is 11m - 100m

Xcellbio has 11 - 50 employees.